Krystal Biotech, Inc. KRYS
Analyst Consensus
Price Objectif
Analyst historical
| Analyste | Entreprise | Prix lors de l'analyse | Prix cible | Gain potentiel | Date de publication |
|---|---|---|---|---|---|
| Dae Gon Ha | Stifel Nicolaus | 185 $ | 220 $ | 35.00 % | 11/09/2024 |
| Alec Stranahan | Bank of America Securities | 195.12 $ | 205 $ | 9.88 % | 02/09/2024 |
| Gavin Clark-Gartner | Evercore ISI | 182.17 $ | 206 $ | 23.83 % | 12/08/2024 |
| Dae Gon Ha | Stifel Nicolaus | 169.75 $ | 204 $ | 34.25 % | 15/04/2024 |
| Geulah Livshits | Chardan Capital | 78.05 $ | 133 $ | 54.95 % | 07/11/2022 |
| Geulah Livshits | Chardan Capital | 82.4 $ | 130 $ | 47.60 % | 08/08/2022 |